Established cell lines transformed by E2F-1 overexpression contain wild-type p53

Cell Proliferation

Volumn 29, Issue 11, 1996, Pages 579-588

  Sladek, T L ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA TRANSFECTION; ETIOLOGY; FIBROBLAST CULTURE; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; REPORTER GENE; TRANSACTIVATION;

ANIMALIA;

EID: 0030436262     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1996.tb00973.x     Document Type: Article

References (49)

1. AARONSON SA, TODARO GJ. (1968) Development of 3T3-like lines from Balb/c mouse embryo cultures: transformation susceptibility to SV40. J. Cell. Physiol. 72, 141.
2. ASKEW D, ASUMUN R, SIMMONS B, CLEVELAND J. (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915.
3. AUSUBEL FM, BRENT R, KINGSTON RE et al. (eds) (1987) Current protocols in molecular biology. New York: John Wiley & Sons.
4. CHO Y, SVETLANA G, JEFFREY PD, PAVLETICH NP. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorgenic mutations. Science 265, 346.
5. DANOS O, MULLIGAN RC. (1988) Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Nat. Acad. Sci. USA 85, 6460.
6. DEBBAS M, WHITE E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7, 546.
7. DONEHOWER LA, BRADLEY A. (1993) The tumor suppressor p53. Biochim. Biophys. Acta 1155, 181.
8. EVAN GI, WYLLIE AH, GILBERT CS et al. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119.
9. FISHER DE. (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 74, 957.
10. FUNK WD, PAK DT, KARAS RH, WRIGHT WE, SHAY JW. (1992) A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12, 2866.
11. GANNON JV, GREAVES R, IGGO R, LANE DP. (1990) Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J. 9, 1595.
12. HARLOW E, CRAWFORD LV, PIM DC, WILLIAMSON NM. (1981) Monoclonal antibodies specific for simian virus 40 tumor antigen. J. Virol. 39, 861.
13. HARRIS CC, HOLLSTEIN M. (1993) Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329, 1318.
14. HARVEY DM, LEVINE AJ. (1991) p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5, 2376.
15. HERMEKING H, EICK D. (1994) Mediation of c-Myc-induced apoptosis by p53. Science 265, 2091.
16. HIEBERT SW, PACKHAM G, STROM DK et al. (1995) E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15, 6864.
17. HOLLSTEIN M, SIDRANSKY D, VOGELSTEIN B, HARRIS CC. (1991) p53 mutations in human cancers. Science 253, 49.
18. HOWES KA, RANSOM, N, PAPERMASTER DS, LASUDRY JGH, ALBERT DM, WINDLE JJ. (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8, 1300.
19. KOWALIK TF, DEGREGORI J, SCHWARZ JK, NEVINS JR. (1995) E2F1 overexpression in quiescent fibroblast leads to induction of cellular DNA synthesis and apoptosis. Mol. Cell. Biol. 69, 2491.
20. LANE DP. (1994) p53 and human cancers. Br. Med. Bull. 50, 582.
21. LEVINE AJ. (1993) The tumor suppressor genes. Annu. Rev. Biochem. 62, 623.
22. LEVINE AJ, PERRY ME, CHANG A et al. (1994) The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer 69, 409.
23. LOGAN TJ, JORDAN KL, HALL D. (1994) Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor. Mol. Biol. Cell. 5, 667.
24. LOWE SW, JACKS T, HOUSMAN DE, RULEY HE. (1994) Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA 91, 2026.
25. LOWE SW, RULEY HE. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7, 535.
26. MOMAND J., ZAMBETTI GP, OLSON DC, GEORGE D, LEVINE AJ. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237.
27. MORGENBESSER SD, WILLIAMS BO, JACKS T, DEPINHO RA. (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371, 72.
28. PAN H, GRIEP AE. (1994) Altered cell cycle regulation in the lens of HPV-17 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8, 1285.
29. QIN X-Q, LIVINGSTON DM, KAELIN JR. WG, ADAMS PD. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918.
30. RAO L, DEBBAS M, SABBATINI P, HOCKENBERY D, KORSMEYER S, WHITE E. (1992) The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89, 7742.
31. REZNIKOFF CA, BRANKOW DW, HEIDELBERGER C. (1973) Establishment and characterization of a cloned cell line of C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 33, 3231.
32. RITTLING SR, DENHARDT DT. (1992) p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells. Oncogcne 7, 935.
33. SHAN B, LEE W-H. (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166.
34. SHAN B, ZHU X, CHEN P-L, DURFEE T, YANG Y, SHARP D, LEE W-H. (1992) Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12, 5620.
35. SINGH P, WONG SH, HONG W. (1994) Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13, 3329.
36. SLADEK TL, FISHER SD, RUBENSTEIN BN. (1994) Dose-response of two cellular proliferation phenotypes produced by simian virus 40 large T antigen. Cell Prolif. 27, 711.
37. SLADEK TL, JACOBBERGER JW. (1990) Rapid titration of retroviral vectors encoding intracellular antigens by flow cytometry. J. Virol. 64, 3135.
38. STELLER H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445.
39. STRASSER A, HARRIS AW, JACKS T, CORY S. (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329.
40. TAN T-H, WALLIS J, LEVINE AJ. (1986) Identification of the p53 protein domain involved in formation of the simian virus 40 large T antigen-p53 protein complex. J. Virol. 59, 574.
41. THOMPSON CB. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456.
42. VOGELSTEIN B, KINZLER KW. (1992) p53 function and dysfunction. Cell 70, 523.
43. wafI/cipI. Genes Dev. 8, 2817.
44. WHITE E, CIPRIANI R, SABBATINI P, DENTON A. (1991) The adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65, 2968.
45. WU X, LEVINE AJ. (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602.
46. XU G, LIVINGSTON DM, KREK W. (1995) Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92, 1357.
47. YANG X-H, SLADEK TL. (1995a) Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr. 4, 195.
48. YANG X-H, SLADEK TL. (1995b) Growth of anchorage-dependent mammalian cells on plastic petri dishes. In Vitro Cell. Dev. Biol. 31, 430.
49. YEDWELL J, GANNON JV, LANE DP. (1986) Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol. 59, 444.